药物对比
Pioglitazone vs Dulaglutide
Pioglitazone 与 Dulaglutide 治疗2型糖尿病：口服TZD vs 每周一次GLP-1注射。比较作用机制、体重影响、心血管风险、黑框警告及患者适用性。
此页面暂无可用的对比维度。
临床背景
Triggered when a T2DM patient on or considering a TZD needs intensification or switch due to weight gain, heart-failure risk, or desire for proven CV benefit from a GLP-1 agonist.
结论
Dulaglutide generally offers more favorable weight and cardiovascular profiles, yet Pioglitazone remains a viable oral alternative when injections are declined and heart failure is absent.
全部药物对比